Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New K+ channel blockers for arrhythmias, ulcers and related disorders

Nov. 2, 1998

How does bradykinin receptor blockade affect responses to ACE inhibition?

Oct. 30, 1998

UT-15 administered successfully to patients with impaired liver function

Oct. 30, 1998

Selective ETA or mixed ETA/ETB antagonist for CHF?

Oct. 29, 1998

Complement inhibitor TP10 improves outcome in pig model of bypass surgery

Oct. 28, 1998

Purepac's generic diltiazem capsules tentatively approved by FDA

Oct. 28, 1998

Glycolipid derivative shows cardioprotective activity in animal models

Oct. 26, 1998

New Na+/H+ exchange inhibitors in development at HMR

Oct. 26, 1998

Potent new PDE5 inhibitor with potential clinical utility

Oct. 23, 1998

New series of antiischemic/antiarrhythmic compounds developed at HMR

Oct. 23, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...